Ten research centers in North America and Europe will attempt to replicate
the recent success of an experimental technique for transplanting insulin-producing
islet cells into patients with type 1 diabetes, the National Institutes of
Health (NIH) announced last month.
Starting this fall, the Immune Tolerance Network (ITN), an international
consortium of clinical researchers who are seeking ways to induce immune tolerance
(as in tolerance of the transplanted islet cells), will expand studies of
the new technique, known as the "Edmonton protocol." About 40 patients with
poorly controlled type 1 diabetes and secondary complications of the disease
will receive islet cell transplants.
Transplant Therapy for Diabetes. JAMA. 2000;284(7):822. doi:10.1001/jama.284.7.822